Aspira Pathlab & Diagnostics Ltd (ASPR)

Currency in INR
64.01
+2.06(+3.33%)
Closed·

ASPR Financial Summary

Key Ratios

P/E Ratio27.78
Price/Book4.64
Debt / Equity26.27%
Return on Equity18.13%
Dividend Yield0.00%
EBITDA35.25M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
31/03
2017
31/03
2018
31/03
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
2025
31/03
* In Millions of INR (except for per share items)

Earnings

Latest Release
May 16, 2025
EPS / Forecast
0.66 / --
Revenue / Forecast
59.07M / --
EPS Revisions
Last 90 days

FAQ

What were Aspira Pathlab's earnings for the latest quarter?

The Aspira Pathlab EPS (TTM) is 1.97. Aspira Pathlab reported sales of 57.77, net income of 6.81, and EPS of 0.66 for the latest quarter.

What was Aspira Pathlab's net income for the latest quarter?

Aspira Pathlab's net income for the latest quarter was 6.81.

How did Aspira Pathlab's performance compare year-over-year in the latest quarter?

The company's revenue moved from 54.07 in the previous quarter to 57.77 in the latest quarter, and net income moved from 3.06 to 6.81 compared to the previous quarter.

What is Aspira Pathlab's net profit margin on a TTM basis?

Aspira Pathlab's trailing twelve months (TTM) net profit margin is 9.19%.

How does Aspira Pathlab's debt to equity ratio compare to industry standards?

Aspira Pathlab's total debt-to-equity ratio is 26.27%.

What is Aspira Pathlab's return on investment on a TTM basis?

Aspira Pathlab's trailing twelve months (TTM) return on investment (ROI) is 18.13%.

What were Aspira Pathlab's total assets and liabilities in the latest quarter?

As of the latest quarter, Aspira Pathlab reported total assets of 174.62 million and total liabilities of 23.72 million.

How has Aspira Pathlab's total revenue grown this year?

Aspira Pathlab's total revenue was 54.07 in the previous quarter and 57.77 in the latest quarter.

What is Aspira Pathlab's gross margin on a TTM basis?

Aspira Pathlab's trailing twelve months (TTM) gross margin is 45.37%.

What was Aspira Pathlab's revenue per share for the latest quarter?

Aspira Pathlab's revenue per share for the latest quarter was 121.18.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.